# OrphanCure Full Pipeline Report: repodb_0f5d00f3cf88c277

- Drug: Prednisolone
- Disease: Bacterial keratitis
- Mode: no_verifier
- Status: completed
- Final assessment: Unlikely

This generated report is for research support only and is not medical advice.

## Structured Output

```json
{
  "sections": {
    "1_executive_summary": {
      "conclusion": "Unlikely",
      "confidence": "Low",
      "summary": "No literature was retrieved to support or refute the repurposing of prednisolone for autosomal dominant keratitis-ichthyosis-hearing loss syndrome. Therefore, the hypothesis is currently unsupported.",
      "evidence_counts": {
        "total_papers": 0,
        "supporting": 0,
        "contradicting": 0,
        "inconclusive": 0
      },
      "common_targets_count": 0
    },
    "2_normalized_hypothesis": {
      "statement": "Repurpose PREDNISOLONE for autosomal dominant keratitis-ichthyosis-hearing loss syndrome",
      "drug": {
        "id": "CHEMBL131",
        "name": "PREDNISOLONE",
        "aliases": [
          "Prednisolone sodium phosphate",
          "Prednisolone acetate",
          "Pediapred",
          "Delta-Cortef",
          "AK-Pred"
        ],
        "resolution_method": "auto"
      },
      "disease": {
        "id": "MONDO_0007850",
        "name": "autosomal dominant keratitis-ichthyosis-hearing loss syndrome",
        "aliases": [
          "keratitis-ichthyosis-hearing loss syndrome, autosomal dominant",
          "KID syndrome",
          "keratitis-ichthyosis-deafness syndrome",
          "keratitis, ichthyosis, and deafness",
          "keratitis-ichthyosis-deafness syndrome, autosomal dominant"
        ],
        "resolution_method": "auto"
      }
    },
    "3_mechanistic_rationale": {
      "total_mechanisms": 0,
      "mechanisms": []
    },
    "4_target_overlap_summary": {
      "total_overlapping": 0,
      "top_targets": []
    },
    "5_literature_evidence_summary": {
      "total_retrieved": 0,
      "polarity": {
        "supports": 0,
        "contradicts": 0,
        "inconclusive": 0
      },
      "support_ratio": "No papers retrieved",
      "queries_used": 10,
      "top_papers": []
    },
    "6_contradictory_evidence": {
      "count": 0,
      "claims": []
    },
    "7_confidence_assessment": {
      "overall": "Low",
      "dimensions": {
        "mechanistic_strength": "Low",
        "literature_strength": "Low",
        "clinical_evidence": "Low"
      },
      "quality_scorecard": {
        "overall_score": 0.388,
        "decision": "rerun",
        "dimensions": {
          "completeness": {
            "score": 0.8,
            "reason": "4/5 sections present"
          },
          "evidence_support": {
            "score": 0.0,
            "reason": "No claims generated"
          },
          "citation_validity": {
            "score": 0.0,
            "reason": "0 total citations"
          },
          "mechanistic_specificity": {
            "score": 0.0,
            "reason": "0/0 claims reference targets"
          },
          "contradiction_handling": {
            "score": 0.3,
            "reason": "No contradiction analysis"
          },
          "traceability": {
            "score": 0.0,
            "reason": "0/0 claims have provenance"
          },
          "output_structure": {
            "score": 1.0,
            "reason": "Executive summary + confidence assessment"
          },
          "actionability": {
            "score": 1.0,
            "reason": "3 next steps, 3 data gaps identified"
          }
        },
        "weak_dimensions": [
          "evidence_support",
          "citation_validity",
          "mechanistic_specificity",
          "contradiction_handling",
          "traceability"
        ],
        "rerun_targets": [
          "LiteratureAgent",
          "MechanismAgent",
          "SynthesisCriticAgent"
        ]
      }
    },
    "8_risk_flags_limitations": {
      "risk_flags": [
        "Lack of direct evidence.",
        "Potential for off-target effects of prednisolone."
      ],
      "limitations": [
        "The analysis is severely limited by the absence of any retrieved literature.",
        "The current assessment is based solely on the lack of supporting data, not on any negative findings."
      ],
      "missing_data": [
        "Literature supporting the use of prednisolone for this specific syndrome.",
        "Information on the molecular targets and pathways involved in autosomal dominant keratitis-ichthyosis-hearing loss syndrome.",
        "Pre-clinical or clinical data on prednisolone's effect on the disease phenotype."
      ]
    },
    "9_recommended_next_steps": {
      "clinical_next_steps": [
        "Conduct a thorough literature search using a wider range of keywords and databases.",
        "Investigate potential shared molecular pathways or targets between prednisolone and the underlying mechanisms of autosomal dominant keratitis-ichthyosis-hearing loss syndrome.",
        "If mechanistic links are identified, consider in vitro or in vivo studies to evaluate prednisolone's efficacy."
      ]
    },
    "10_claim_evidence_table": {
      "total_claims": 0,
      "claims": []
    },
    "11_provenance_appendix": {
      "total_entries": 0,
      "entries": []
    }
  },
  "metadata": {
    "run_id": "15dc23ddc42c",
    "created_at": "2026-06-03T14:34:19.372943+00:00",
    "drug": "PREDNISOLONE",
    "disease": "autosomal dominant keratitis-ichthyosis-hearing loss syndrome",
    "total_claims": 0,
    "quality_score": 0.3875,
    "reruns": 0
  }
}
```
